Ayten Kandilci

3PUBLICATIONS
8CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 03, 2022
Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2.

Emrah Özçelik, Ahmet Kalaycı, Büşra Çelik

|Sep 07, 2020
Identification of novel TUBB1 variants in patients with macrothrombocytopenia.

Zihni Onur Çalışkaner, Abdullah Abdul Waheed, Merve Tuzlakoğlu Öztürk

|May 31, 2017
DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

Zihni Onur Çalışkaner, Türkan Çakar, Emrah Özçelik

Pageof 1

Frequent Collaborators

1 joint publications

Zihni Onur Çalışkaner

1 joint publications

Abdullah Abdul Waheed

1 joint publications

Merve Tuzlakoğlu Öztürk

1 joint publications

Yeşim Oymak